Attend the #ISHLTAcademy in Infectious Disease/Pharmacy: From Pathogens to Pharmacokinetics - Optimizing Outcomes in Thoracic Transplant in Toronto. 🦠💊
📅 Tuesday, 21 April
➡️ Explore the program + register: 🔗 https://t.co/14mRYudQcj
#InfectiousDiseases#PharmacyTx #ThoracicTx #transplantation #ISHLT2026
Attend the #ISHLTAcademy in Infectious Disease/Pharmacy: From Pathogens to Pharmacokinetics - Optimizing Outcomes in Thoracic Transplant in Toronto. 🦠💊
📅 Tuesday, 21 April
➡️ Explore the program + register: 🔗 https://t.co/14mRYudQcj
#InfectiousDiseases#PharmacyTx #ThoracicTx #transplantation #ISHLT2026
Our new study in Transpl Infect Dis found that switching TMP/SMX→atovaquone didn’t reduce #hyperkalemia but was linked to ↑infection risk—and it’s been spotlighted in a Wiley editorial! 📰🔬
📰 https://t.co/DLWqOhq2jS
📄 https://t.co/5stAWGJpCz
#CardioTwitter#Transplant
@PharmDaryl presents an excellent talk on the 2 Ps! Point of Care Testing for INR and PharmD. Also consider lowering inr to 2.0-2.5 for hmIII patients. Time in therapeutic range (TTR) paramount. @ISHLT#ISHLT2024
Ending #ISHLT2023 on a high note! Thanks to my team for being nothing short of amazing. Thanks to @VADCoordinator and @ISHLT for this opportunity. See y'all again in Prague for #ISHLT2024.
🚨The world’s first HIV-positive to HIV-positive #hearttransplant has been successfully performed at Montefiore.
Congratulations to Drs. Ulrich Jorde, Omar Saeed, Daniel Goldstein & the heart transplant team @MonteHeart on this history-making achievement.
https://t.co/Qcrkr9CUYk
An incredible overview of immunosuppression for 🫀transplant recipients by the one and only @PharmDaryl at this morning’s #MonteHeart Fellows Conference.
A sneak peek ⬇️
@ISHLT#ISHLT2021
Has anyone noticed an increase in tacrolimus trough levels after initiation of glecaprevir/pibrentasvir in SOT recipients receiving HCV NAT+ organs? Check out our preliminary findings at ATC. https://t.co/F1aq5SzrEL
#ATC2020VIRTUAL